Company Executives

Management Team

From the proxy statement filed Apr 7, 2026

Officer	Age	In this role	Joined	Pay
Xi-Yong (Sean) Fu Also a director Director and Chief Executive Officer	54	Since 2024 2 years	Not stated	Not reported
Srishti Gupta Chief Executive Officer Title from the Form 4 dated Jul 6, 2026	Not stated	Not stated	Not stated	Not reported
Ming (Kyler) Lei Chief Financial Officer	29	Since 2025 1 year	Not stated	Not reported
Phillip Dennis Chief Medical Officer	63	Since 2024 2 years	Not stated	Not reported
Liwei (Lorraine) Lin General Counsel	38	Since 2026 this year	Not stated	Not reported
Mark Arnold Hagler Chief Commercial Officer Title from the Form 4 dated Jul 8, 2026	Not stated	Not stated	Not stated	Not reported
Cong (Claire) Xu EVP, Clinical Development Title from the Form 4 dated Aug 30, 2026	41	Not stated	Not stated	Not reported
Sean Wuxiong Cao Also a director Chief Bus. Development Officer Title from the Form 4 dated Sep 9, 2026	59	Not stated	Not stated	Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors

serving now

Independent

4 of 4

stated in the proxy; 5 not stated

Average tenure

2.9 years

from year joined

CEO also chairs the board

Wei Fu

Director	Age	On board	Independent	Committees	Other public boards	Pay
Wei Fu Board chair, Executive officer	43	2018 8 years	Not stated	Compensation Committee · Chair Nominating and Corporate Governance Committee · Chair	None stated	Not stated
Xi-Yong (Sean) Fu CEO, Executive officer	54	2024 2 years	Not stated	Research and Development Committee Environmental, Social and Governance Committee	None stated	Paid as CEO
Sean Wuxiong Cao Executive officer	59	2025 1 year	Not stated	Research and Development Committee	None stated	Not stated
Emmett T. Cunningham, Jr.	65	2026 0 years	Not stated	Research and Development Committee	None stated	Not stated
Chun Kwok Alan Au	53	2020 6 years	Independent	Audit Committee Compensation Committee Nominating and Corporate Governance Committee Environmental, Social and Governance Committee · Chair	None stated	Not stated
Conor Chia-hung Yang	63	2020 6 years	Independent	Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee	None stated	Not stated
Robert Lenz	55	2025 1 year	Independent	Research and Development Committee · Chair	None stated	Not stated
Xin Liu	37	2025 1 year	Independent	Audit Committee	None stated	Not stated
Ian Ying Woo	53	2025 1 year	Not stated	Nominating and Corporate Governance Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. NovaBridge Biosciences has not filed one with the SEC.

Comments